Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-15

Clinical Trial Update: Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the impact of Risperdal Consta on the benefit of social skills training in patients with schizophrenia or schizoaffective diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED